Outlook Therapeutics Inc (OTLK)

Sep 08, 2026

These 3 Stocks Led Wall Street’s Biggest Gains On Tuesday – Here’s Why - Stocktwits

Sep 08, 2026

Sep 07, 2026

AMZN: Amazon.com Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 07, 2026

Sep 07, 2026

OTLK Stock Rocket Nearly 140%: FDA's Lytenava FDR Approval Pushes Stock On Track For Best Week On Record - Stocktwits

Sep 07, 2026

Sep 06, 2026

Nasdaq Futures Lead US Premarket Rally As Iran Ceasefire Reports Ease Fears Ahead Of Big Tech Earnings: Why NVDA, ORCL, SPCX, XOM, OTLK Are In Focus - Stocktwits

Sep 06, 2026

Sep 06, 2026

OTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal - Stocktwits

Sep 06, 2026

Sep 06, 2026

OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision - Stocktwits

Sep 06, 2026

Sep 05, 2026

Outlook Therapeutics Stock Price Forecast. Should You Buy OTLK? - StockInvest.us

Sep 05, 2026

Sep 03, 2026

People on the Move: Kevin Lundquist Named Chief Financial Officer of Outlook Therapeutics - BioBuzz

Sep 03, 2026

Sep 02, 2026

CFO at Outlook Therapeutics (NASDAQ: OTLK) gets 500,000 hiring options - Stock Titan

Sep 02, 2026

Sep 02, 2026

Outlook Therapeutics (NASDAQ: OTLK) CFO reports zero insider holdings - Stock Titan

Sep 02, 2026

Aug 28, 2026

Outlook Therapeutics Announces CFO Transition and Board Change - The Globe and Mail

Aug 28, 2026

Aug 28, 2026

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™ - Sahm

Aug 28, 2026

Aug 28, 2026

Lundquist appointed chief financial officer at Outlook Therapeutics of Iselin - roi-nj.com

Aug 28, 2026

Aug 28, 2026

Outlook Therapeutics Names Kevin Lundquist CFO Ahead of Lytenava U.S. Launch - VisionMonday.com

Aug 28, 2026

Aug 27, 2026

Outlook Therapeutics appoints Kevin Lundquist as CFO as Lawrence Kenyon to depart - TradingView

Aug 27, 2026

Aug 27, 2026

Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 - marketscreener.com

Aug 27, 2026

Aug 19, 2026

Outlook Therapeutics(OTLK) Stock Options Chain | Quotes & News - Moomoo

Aug 19, 2026

Aug 19, 2026

Outlook Therapeutics (OTLK) investor held to 9.99% cap - Stock Titan

Aug 19, 2026

Aug 19, 2026

Outlook Therapeutics Inc (OTLK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aug 19, 2026

Aug 18, 2026

Outlook Therapeutics, Inc. 2026: Revenue $8.7K, EPS ($0.15) — 10-Q Summary - TradingView

Aug 18, 2026

Aug 18, 2026

Outlook Therapeutics (OTLK) wins FDA exclusivity but holds limited cash - Stock Titan

Aug 18, 2026

Aug 18, 2026

Brookline Capital cuts Outlook Therapeutics stock price target on model update - Investing.com

Aug 18, 2026

Aug 17, 2026

Outlook Therapeutics delays quarterly SEC filing - TipRanks

Aug 17, 2026

Aug 17, 2026

META_TITLE_QUOTE - Yahoo Finance

Aug 17, 2026

Aug 17, 2026

OTLK Q3 Earnings Call Maps LYTENAVA U.S. Launch and Sales Ramp - Yahoo Finance

Aug 17, 2026

Aug 17, 2026

Outlook Therapeutics Insider Bought Shares Worth $2,499,999, According to a Recent SEC Filing - moomoo.com

Aug 17, 2026

Aug 17, 2026

Outlook Therapeutics Posts Q3 Financials, Raises Funds for Lytenava Launch - VisionMonday.com

Aug 17, 2026

Aug 16, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 16, 2026

Aug 16, 2026

Outlook Therapeutics Inc (OTLK) Stock News Today - TradingKey

Aug 16, 2026

Aug 16, 2026

MSN Money - MSN

Aug 16, 2026

Aug 15, 2026

Outlook Therapeutics CEO Robert Jahr acquires shares and warrants for $0 - Investing.com South Africa

Aug 15, 2026

Aug 15, 2026

Outlook Therapeutics (OTLK) Stock May Be No Bargain With Approval But Weak Balance Sheet - finance.yahoo.com

Aug 15, 2026

Aug 15, 2026

Outlook Therapeutics (OTLK) Stock Looks Fully Valued While Book Value Stays Unclear - simplywall.st

Aug 15, 2026

Aug 14, 2026

Outlook Therapeutics CFO Kenyon acquires 101,010 shares By Investing.com - Investing.com South Africa

Aug 14, 2026

Aug 14, 2026

Outlook Therapeutics (OTLK) CEO purchases 151,515 shares and matching warrants - Stock Titan

Aug 14, 2026

Aug 14, 2026

Outlook Therapeutics, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:OTLK) 2026-08-14 - Seeking Alpha

Aug 14, 2026

Aug 14, 2026

Outlook Therapeutics director Ghiath Sukhtian buys $2.5m in shares By Investing.com - Investing.com Australia

Aug 14, 2026

Aug 14, 2026

Outlook Therapeutics director Ghiath Sukhtian buys $2.5m in shares - Investing.com

Aug 14, 2026

Aug 14, 2026

Outlook Therapeutics CFO Kenyon acquires 101,010 shares - Investing.com

Aug 14, 2026